NFKB1 and acute respiratory distress syndrome: Another study has signified that intravenous infusion of BMMSC-Exo decreased levels of pro-inflammatory cytokines, prohibited apoptotic protein activation, and also TLR4/NF-κB signaling in ALI models, suggesting that Exo therapy can be a non-cellular alternative to MSC transplantation [90].